These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29211393)

  • 1. The impact of metformin use on the risk of prostate cancer after prostate biopsy in patients with high grade intraepithelial neoplasia.
    Dell'Atti L; Galosi AB
    Int Braz J Urol; 2018; 44(1):69-74. PubMed ID: 29211393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin Does Not Predict for Prostate Cancer Diagnosis, Grade, or Volume of Disease After Transperineal Template-guided Mapping Biopsy.
    Merrick GS; Bennett A; Couture T; Butler WM; Galbreath RW; Adamovich E
    Am J Clin Oncol; 2017 Aug; 40(4):353-357. PubMed ID: 25575041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERG overexpression and multifocality predict prostate cancer in subsequent biopsy for patients with high-grade prostatic intraepithelial neoplasia.
    Shah RB; Li J; Dhanani N; Mendrinos S
    Urol Oncol; 2016 Mar; 34(3):120.e1-7. PubMed ID: 26585946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial.
    Milonas D; Auskalnis S; Skulcius G; Gudinaviciene I; Jievaltas M; Joniau S
    World J Urol; 2017 May; 35(5):721-728. PubMed ID: 27644229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of isolated high-grade prostatic intra-epithelial neoplasia: proposal of a nomogram for the prediction of cancer detection at saturation re-biopsy.
    Roscigno M; Scattoni V; Freschi M; Abdollah F; Maccagnano C; Galosi A; Lacetera V; Montironi R; Muzzonigro G; Deho F; Deiana G; Belussi D; Chinaglia D; Montorsi F; Da Pozzo LF
    BJU Int; 2012 May; 109(9):1329-34. PubMed ID: 21895935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.
    He H; Osunkoya AO; Carver P; Falzarano S; Klein E; Magi-Galluzzi C; Zhou M
    BJU Int; 2012 Dec; 110(11 Pt B):E751-5. PubMed ID: 23046279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widespread high grade prostatic intraepithelial neoplasia on biopsy predicts the risk of prostate cancer: a 12 months analysis after three consecutive prostate biopsies.
    De Nunzio C; Albisinni S; Cicione A; Gacci M; Leonardo C; Esperto F; Tubaro A
    Arch Ital Urol Androl; 2013 Jun; 85(2):59-64. PubMed ID: 23820650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of high-grade prostatic intraepithelial neoplasia: the impact of the number of biopsy cores at initial sampling on cancer detection after a saturation re-biopsy.
    Roscigno M; Scattoni V; Freschi M; Raber M; Angiolilli D; Galosi A; Lacetera V; Montironi R; Muzzonigro G; Deho F; Feroldi L; Deiana G; Chinaglia D; Montorsi F; Da Pozzo LF
    Arch Ital Urol Androl; 2010 Dec; 82(4):242-7. PubMed ID: 21341572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma.
    Netto GJ; Epstein JI
    Am J Surg Pathol; 2006 Sep; 30(9):1184-8. PubMed ID: 16931964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive predictive value of high-grade prostatic intraepithelial neoplasia in initial core needle biopsies of prostate adenocarcinoma--a study with complete sampling of hemi-prostates with corresponding negative biopsy findings.
    Delatour NL; Mai KT
    Urology; 2008 Sep; 72(3):623-7. PubMed ID: 18279923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
    Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
    Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low testosterone level predicts prostate cancer in re-biopsy in patients with high grade prostatic intraepithelial neoplasia.
    García-Cruz E; Piqueras M; Ribal MJ; Huguet J; Serapiao R; Peri L; Izquierdo L; Alcaraz A
    BJU Int; 2012 Sep; 110(6 Pt B):E199-202. PubMed ID: 22257176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.
    Taneja SS; Morton R; Barnette G; Sieber P; Hancock ML; Steiner M
    J Clin Oncol; 2013 Feb; 31(5):523-9. PubMed ID: 23295793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of Clinically Significant Prostate Cancer After a Diagnosis of Atypical Small Acinar Proliferation, High-grade Prostatic Intraepithelial Neoplasia, or Benign Tissue.
    Wiener S; Haddock P; Cusano J; Staff I; McLaughlin T; Wagner J
    Urology; 2017 Dec; 110():161-165. PubMed ID: 28888752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with metabolic syndrome and widespread high grade prostatic intraepithelial neoplasia are at a higher risk factor of prostate cancer on re-biopsy: a prospective single cohort study.
    Cicione A; Cantiello F; De Nunzio C; Tubaro A; Damiano R
    Urol Oncol; 2014 Jan; 32(1):28.e27-31. PubMed ID: 23273912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy.
    De Nunzio C; Trucchi A; Miano R; Stoppacciaro A; Fattahi H; Cicione A; Tubaro A
    J Urol; 2009 Mar; 181(3):1069-74; discussion 1074-5. PubMed ID: 19150546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin use and risk of prostate cancer: results from the REDUCE study.
    Feng T; Sun X; Howard LE; Vidal AC; Gaines AR; Moreira DM; Castro-Santamaria R; Andriole GL; Freedland SJ
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1055-60. PubMed ID: 26353947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of high-grade prostatic intraepithelial neoplasia (HGPIN): risk of prostatic cancer on repeat biopsies.
    Gallo F; Chiono L; Gastaldi E; Venturino E; Giberti C
    Urology; 2008 Sep; 72(3):628-32. PubMed ID: 18279918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer?
    Goeman L; Joniau S; Ponette D; Van der Aa F; Roskams T; Oyen R; Van Poppel H
    Prostate Cancer Prostatic Dis; 2003; 6(4):305-10. PubMed ID: 14663472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.